Literature DB >> 31101435

A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Natalie A Villani1, Garrett Bullock1, Jennifer R Michaels2, Osamu Yamato3, Dennis P O'Brien1, Tendai Mhlanga-Mutangadura1, Gary S Johnson1, Martin L Katz4.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by progressive declines in neurological functions following normal development. The NCLs are distinguished from similar disorders by the accumulation of autofluorescent lysosomal storage bodies in neurons and many other cell types, and are classified as lysosomal storage diseases. At least 13 genes contain pathogenic sequence variants that underlie different forms of NCL. Naturally occurring canine NCLs can serve as models to develop better understanding of the disease pathologies and for preclinical evaluation of therapeutic interventions for these disorders. To date 14 sequence variants in 8 canine orthologs of human NCL genes have been found to cause progressive neurological disorders similar to human NCLs in 12 different dog breeds. A mixed breed dog with parents of uncertain breed background developed progressive neurological signs consistent with NCL starting at approximately 11 to 12 months of age, and when evaluated with magnetic resonance imaging at 21 months of age exhibited diffuse brain atrophy. Due to the severity of neurological decline the dog was euthanized at 23 months of age. Cerebellar and cerebral cortical neurons contained massive accumulations of autofluorescent storage bodies the contents of which had the appearance of tightly packed membranes. A whole genome sequence, generated with DNA from the affected dog contained a homozygous C-to-T transition at position 30,574,637 on chromosome 22 which is reflected in the mature CLN5 transcript (CLN5: c.619C > T) and converts a glutamine codon to a termination codon (p.Gln207Ter). The identical nonsense mutation has been previously associated with NCL in Border Collies, Australian Cattle Dogs, and a German Shepherd-Australian Cattle Dog mix. The current whole genome sequence and a previously generated whole genome sequence for an Australian Cattle Dog with NCL share a rare homozygous haplotype that extends for 87 kb surrounding 22: 30, 574, 637 and includes 21 polymorphic sites. When genotyped at 7 of these polymorphic sites, DNA samples from the German Shepherd-Australian Cattle Dog mix and from 5 Border Collies with NCL that were homozygous for the CLN5: c.619 T allele also shared this homozygous haplotype, suggesting that the NCL in all of these dogs stems from the same founding mutation event that may have predated the establishment of the modern dog breeds. If so, the CLN5 nonsence allele is probably segregating in other, as yet unidentified, breeds. Thus, dogs exhibiting similar NCL-like signs should be screened for this CLN5 nonsense allele regardless of breed.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CLN5; Dog; Lysosomal storage disease; Neurodegeneration; Neuronal ceroid lipofuscinosis; Whole genome sequencing

Mesh:

Substances:

Year:  2019        PMID: 31101435      PMCID: PMC6555421          DOI: 10.1016/j.ymgme.2019.04.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  60 in total

1.  A variant form of neuronal ceroid lipofuscinosis in American bulldogs.

Authors:  Jason Evans; Martin L Katz; Donald Levesque; G Diane Shelton; Alexander de Lahunta; Dennis O'Brien
Journal:  J Vet Intern Med       Date:  2005 Jan-Feb       Impact factor: 3.333

2.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Authors:  Gail M Seigel; Andrew Lotery; Ari Kummer; David J Bernard; Nicholas D E Greene; Mark Turmaine; Todd Derksen; Robert L Nussbaum; Beverly Davidson; Janet Wagner; Hannah M Mitchison
Journal:  Mol Cell Neurosci       Date:  2002-04       Impact factor: 4.314

4.  Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.

Authors:  J D Cooper; A Messer; A K Feng; J Chua-Couzens; W C Mobley
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

5.  A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis.

Authors:  Tomoyuki Awano; Martin L Katz; Dennis P O'Brien; Jeremy F Taylor; Jason Evans; Shahnawaz Khan; Istvan Sohar; Peter Lobel; Gary S Johnson
Journal:  Mol Genet Metab       Date:  2006-01-04       Impact factor: 4.797

6.  A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.

Authors:  Martin L Katz; Shahnawaz Khan; Tomoyuki Awano; S Adam Shahid; Aristotle N Siakotos; Gary S Johnson
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

7.  A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs.

Authors:  Scott A Melville; Carmen L Wilson; Chiu S Chiang; Virginia P Studdert; Frode Lingaas; Alan N Wilton
Journal:  Genomics       Date:  2005-09       Impact factor: 5.736

8.  Clenbuterol retards loss of motor function in motor neuron degeneration mice.

Authors:  Richard J Zeman; Hong Peng; Joseph D Etlinger
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

9.  Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system.

Authors:  M Bertamini; B Marzani; R Guarneri; P Guarneri; P Bigini; T Mennini; D Curti
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

10.  Neuronal ceroid-lipofuscinosis in a Labrador Retriever.

Authors:  John H Rossmeisl; Robert Duncan; Jonathan Fox; Erin S Herring; Karen D Inzana
Journal:  J Vet Diagn Invest       Date:  2003-09       Impact factor: 1.279

View more
  7 in total

1.  Screening and Carrier Rate of Neuronal Ceroid Lipofuscinosis in Chihuahua Dogs in Japan.

Authors:  Shahnaj Pervin; Md Shafiqul Islam; Naomi Tada; Toshihiko Tsutsui; Mohammad Mahbubur Rahman; Akira Yabuki; Martia Rani Tacharina; Tofazzal Md Rakib; Shinichiro Maki; Osamu Yamato
Journal:  Animals (Basel)       Date:  2022-05-07       Impact factor: 3.231

Review 2.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

3.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

4.  Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant.

Authors:  Juyuan Guo; Gary S Johnson; James Cook; Olivia K Harris; Tendai Mhlanga-Mutangadura; Robert D Schnabel; Cheryl A Jensen; Martin L Katz
Journal:  Mol Genet Metab Rep       Date:  2019-10-21

5.  Evaluation of genetic diversity and management of disease in Border Collie dogs.

Authors:  Pamela Xing Yi Soh; Wei Tse Hsu; Mehar Singh Khatkar; Peter Williamson
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

6.  Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Grace Robinson Kick; Elizabeth J Meiman; Julianna C Sabol; Rebecca E H Whiting; Juri Ota-Kuroki; Leilani J Castaner; Cheryl A Jensen; Martin L Katz
Journal:  Exp Eye Res       Date:  2021-06-30       Impact factor: 3.770

7.  Neuronal Ceroid Lipofuscinosis in a Domestic Cat Associated with a DNA Sequence Variant That Creates a Premature Stop Codon in CLN6.

Authors:  Martin L Katz; Reuben M Buckley; Vanessa Biegen; Dennis P O'Brien; Gayle C Johnson; Wesley C Warren; Leslie A Lyons
Journal:  G3 (Bethesda)       Date:  2020-08-05       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.